UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

Blood, 2011-10, Vol.118 (16), p.4346-4352

2011

Volltextzugriff (PDF)

Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial

Trials, 2013-03, Vol.14 (1), p.73-73

2013

Volltextzugriff (PDF)

Thrombotic Microangiopathy: A Multidisciplinary Team Approach

American journal of kidney diseases, 2017-11, Vol.70 (5), p.715-721

2017

Volltextzugriff (PDF)

Durable renal response after combination of bortezomib, corticosteroids, rituximab, and plasmapheresis for late antibody-mediated renal transplant rejection

Clinical nephrology, 2018-04, Vol.89 (4), p.252

2018

Volltextzugriff (PDF)

SARS-CoV-2 Infection–Associated Hemophagocytic Lymphohistiocytosis

American journal of clinical pathology, 2020-09, Vol.154 (4), p.466-474

2020

Volltextzugriff (PDF)

Granulocyte transfusions in severe aplastic anemia: an eleven-year experience

Haematologica (Roma), 2009-12, Vol.94 (12), p.1661-1668

2009

Volltextzugriff (PDF)

The trials and tribulations of chronic transfusion in pediatric sickle cell disease: progress from STOP to TWiTCH?

Transfusion (Philadelphia, Pa.), 2016-07, Vol.56 (7), p.1673-1674

Quillen, Karen

2016

Volltextzugriff (PDF)

Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions

Transfusion (Philadelphia, Pa.), 2009-09, Vol.49 (9), p.1845-1849

2009

Volltextzugriff (PDF)

Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study

Haematologica (Roma), 2011-12, Vol.96 (12), p.1890-1892

2011

Volltextzugriff (PDF)

Hemolysis from platelet transfusion: call to action for an underreported reaction

Transfusion (Philadelphia, Pa.), 2012-10, Vol.52 (10), p.2072-2074

Quillen, Karen

2012

Volltextzugriff (PDF)

Nonoperative Management of Spontaneous Splenic Rupture in a Patient with Light-Chain Amyloidosis: A Case Report

Journal of vascular and interventional radiology, 2015-10, Vol.26 (10), p.1578-1580

2015

Volltextzugriff (PDF)

In search of plentiful universal donor plasma: what might Landsteiner say?

Transfusion (Philadelphia, Pa.), 2013-08, Vol.53 (8), p.1863-1864

Quillen, Karen

2013

Volltextzugriff (PDF)

In search of plentiful universal donor plasma: what might L andsteiner say?

Transfusion (Philadelphia, Pa.), 2013-08, Vol.53 (8), p.1863-1864

Quillen, Karen

2013

Volltextzugriff (PDF)

Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease

Haematologica (Roma), 2009-07, Vol.94 (7), p.1029-1032

2009

Volltextzugriff (PDF)

Monoclonal IgG4/2κ Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney Transplantation

Kidney medicine, 2019-05, Vol.1 (3), p.139-143

2019

Volltextzugriff (PDF)

Concurrent Presentation of Thrombotic Thrombocytopenic Purpura and Membranous Nephropathy

Kidney international reports, 2018-03, Vol.3 (2), p.476-481

2018

Volltextzugriff (PDF)

Modified High Dose Versus High Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis

Blood, 2020-11, Vol.136 (Supplement 1), p.4-5

2020

Volltextzugriff (PDF)

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience

Blood, 2015-11, Vol.126 (20), p.2345-2347

2015

Volltextzugriff (PDF)

70 Computerized Approach to Antibody Identification in Pretransfusion Testing

American journal of clinical pathology, 2018-01, Vol.149 (suppl_1), p.S200-S200

2018

Volltextzugriff (PDF)

Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation

Blood, 2017-09, Vol.130 (11), p.1383-1386

2017

Volltextzugriff (PDF)

Early Serum Free Light Chain Response after High-Dose Melphalan and Stem Cell Transplantation Predicts Hematologic Response in AL Amyloidosis

Blood, 2020-11, Vol.136 (Supplement 1), p.26-26

2020

Volltextzugriff (PDF)

Blood and bombs: blood use after the B oston M arathon bombing of A pril 15, 2013

Transfusion (Philadelphia, Pa.), 2014-04, Vol.54 (4), p.1202-1203

2014

Volltextzugriff (PDF)

Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation

Blood, 2018-08, Vol.132 (7), p.755-757

2018

Volltextzugriff (PDF)

Safety of Autologous Stem Cell Transplantation in Patients with Known HTLV-1 Infection: A Case Series of 4 Patients

Blood, 2018-11, Vol.132 (Supplement 1), p.5738-5738

2018

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(118)

Publikationsform

Sprache

Englisch
(127)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(64)
Science & Technology
(64)
Humans
(54)
Hematology
(40)
Female
(38)
Middle Aged
(36)
Male
(35)
Adult
(30)
Aged
(29)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Melphalan - Administration & Dosage
(16)
Stem Cell Transplantation
(16)
Amyloidosis - Therapy
(13)
Treatment Outcome
(13)
Transplantation
(11)
Aged, 80 And Over
(10)
Al Amyloidosis
(10)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(9)
Immunology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial

Thrombotic Microangiopathy: A Multidisciplinary Team Approach

Durable renal response after combination of bortezomib, corticosteroids, rituximab, and plasmapheresis for late antibody-mediated renal transplant rejection

SARS-CoV-2 Infection–Associated Hemophagocytic Lymphohistiocytosis

Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection

Granulocyte transfusions in severe aplastic anemia: an eleven-year experience

The trials and tribulations of chronic transfusion in pediatric sickle cell disease: progress from STOP to TWiTCH?

Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions

Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study

Hemolysis from platelet transfusion: call to action for an underreported reaction

Nonoperative Management of Spontaneous Splenic Rupture in a Patient with Light-Chain Amyloidosis: A Case Report

In search of plentiful universal donor plasma: what might Landsteiner say?

In search of plentiful universal donor plasma: what might L andsteiner say?

Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease

Monoclonal IgG4/2κ Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney Transplantation

Concurrent Presentation of Thrombotic Thrombocytopenic Purpura and Membranous Nephropathy

Modified High Dose Versus High Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience

70 Computerized Approach to Antibody Identification in Pretransfusion Testing

Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation

Early Serum Free Light Chain Response after High-Dose Melphalan and Stem Cell Transplantation Predicts Hematologic Response in AL Amyloidosis

Blood and bombs: blood use after the B oston M arathon bombing of A pril 15, 2013

Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation

Safety of Autologous Stem Cell Transplantation in Patients with Known HTLV-1 Infection: A Case Series of 4 Patients

Suchergebnisse filtern